Stable Isotope Labelled Cergutuzumab Biosimilar – Anti-CEACAM5/CEA/CD66e mAb – Research Grade

Reference: PX-TA1387-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Cergutuzumab Biosimilar - Anti-CEACAM5/CEA/CD66e mAb - Research Grade
SourceCAS 1509916-03-3
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsCEA-IL-2v,RG7813,RO-6895882
ReferencePX-TA1387-SIL
Related ProductsPX-P4088
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIG-Gamma1 -[IL2 (interleukin 2, IL-2) 21-153, engineered]1_kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Cergutuzumab Biosimilar - Anti-CEACAM5/CEA/CD66e mAb - Research Grade

General information on Anti-CEACAM5/CEA/CD66e[Homo sapiens] (Cergutuzumab) Monoclonal Antibody

Cergutuzumab is investigated for the treatment of Advanced and/or Metastatic Solid Tumors.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Cergutuzumab Biosimilar – Anti-CEACAM5/CEA/CD66e mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products